Previous close | 0.0001 |
Open | 0.0001 |
Bid | 0.0000 x 0 |
Ask | 0.0001 x 0 |
Day's range | 0.0001 - 0.0001 |
52-week range | 0.0000 - 0.0002 |
Volume | |
Avg. volume | 28,826,123 |
Market cap | 4.055M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 0.00 |
EPS (TTM) | 0.0500 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on March 21, 2024, and that on March 20, 2024, the Company and certain institutional warrant holders agreed that, with regard to Series B Warrants to acquire 101,350,000,000 shares of common stock, subject to certain terms, the termination date of such Warrants would be extended from M
WEST PALM BEACH, Fla., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer, Seamus Lagan provides the following message to shareholders. Dear Fellow Shareholders, As we begin 2024, I want to provide an update on some of our recent accomplishments and outline our plans for the future. Our efforts in recent years to build and sustain a viable business model for our healthcare services operations have gained momentum. 2023 was a significant year for the Compan
WEST PALM BEACH, Fla., Dec. 20, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: INQR) Chief Executive Officer, Darrell Peterson provides the following year end message to shareholders. Dear Fellow Shareholders As we approach the end of 2023 I want to share my optimism about what has been accomplished in 2023 and the strategy and path we have adopted for the coming year. We remain confident that software and IT solutions for the healthcare sector provides unlimited opportunity for growth and value